Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-25T06:33:49.646Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute extrapyramidal symptoms following abrupt discontinuation of propranolol

Published online by Cambridge University Press:  13 June 2014

Ahmad Alavian Ghavanini
Ahmad Alavian Ghavanini*
Affiliation:
Nemazee Hospital, Post Code: 71935, Shiraz, Iran, E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 16 , Issue 4 , December 1999 , pp. 151
Copyright
Copyright © Cambridge University Press 1999

References

1.Gill, HS, DeVane, CL, Risch, SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997; 17(5): 377–89.CrossRefGoogle ScholarPubMed
2.Holloman, LC, Marder, SR. Management of acute extrapyramidal effects induced by antipsychotic drugs. Am J Health Syst Pharm 1997; 54(21): 2461–77.CrossRefGoogle ScholarPubMed
3.Kulik, AV, Wilbur, R. Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor. Frog Neuropsychopharmacol Biol Psychiatry 1983; 7(2-3): 223–5.CrossRefGoogle ScholarPubMed
4.Chaudhry, R, Radonjic, D, Waters, B. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome. Am J Psychiatry 1982 May; 139(5): 674–6.Google Scholar
5.Wilbur, R, Kulik, FA. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms. Frog Neuropsychopharmacol 1980; 4(6): 627–32.CrossRefGoogle ScholarPubMed
6.Kulik, FA, Wilbur, R. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics. Psychopharm Bull 1980; 16(3): 18–9.Google ScholarPubMed
7.Gelenberg, AJ. Treating extrapyramidal reactions: some current issues. J Clin Psychiat 1987 Sep; 48(Suppl): 24–7.Google ScholarPubMed
8.Carpentier, AF, Bonnet, AM, Vidailhet, M, Agid, . Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease. Neurology 1996; Jun; 46(6): 1548–51.CrossRefGoogle ScholarPubMed
9.Kikuchi, T, Uwahodo, Y, Tottori, K, Nakai, M, Morita, S. The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats. Psychopharmacology Berl 1997; 131(2): 108–14.CrossRefGoogle ScholarPubMed
10.Wells, BCet al.A placebo-controlled trial of nadolol in the tteatment of neuroleptic-induced akathisia. J Clin Psychiat 1991; 52(6): 255–60.Google Scholar
11.Vandel, Pet al.Tricyclic antidepressant-induced extrapyramidal side effects. Eur Neuropsychopharmacol 1997; 7(3): 207–12.CrossRefGoogle ScholarPubMed